Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 30, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 3, 2026
CFOOther
Context
Classification
other
Code P, but footnote references an employee stock purchase plan
Planned / mechanical clue
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001100682-26-000144
Filed / recorded
Oct 3, 2026, 12:27 AM UTC
Added to OQRO
Oct 3, 2026, 11:40 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Issuer CIK
1100682
Ticker
CRL
Reporting person
Glenn Coleman
Relationship
Officer
Officer title
EVP & Chief Financial Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Sep 30, 2026
Transaction code
P
Shares / units
10
Price per share
$297.43
Acquired / disposed
Acquired (A)
Shares owned after
27,762
Ownership form
Direct
Amendment
No
Footnotes from the filing
The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period.